• CLA, PPARγ/NFκB, and NEC Barrier Protection

  2026-09-08

  This 2024 Journal of Functional Foods study combined fecal metabolomics, neonatal rat experiments, intestinal cell assays, and RNA sequencing to investigate conjugated linoleic acid (CLA) in necrotizing enterocolitis (NEC). The findings connect reduced linoleic acid compounds with NEC severity and suggest that CLA protects the immature intestine by enhancing PPARγ signaling, restraining NFκB activity, reducing inflammation, and preserving barrier-related cellular homeostasis.

• AhR–RBX1/HSF1 Signaling in Acute Pancreatitis

  2026-09-08

  Fang and colleagues identify aryl hydrocarbon receptor signaling as a regulator of pancreatic tight-junction injury in experimental acute pancreatitis. Their data connect AhR with RBX1-dependent control of HSF1 and macrophage polarization, while pharmacologic disruption with triptolide weakens the protective phenotype.

• Circadian Glycogen Biology: From Mice to Translation

  2026-09-07

  Circadian exercise research is revealing that performance adaptation cannot be explained by bulk glycogen alone. This thought-leadership article shows how a glucose-derived colorimetric readout can strengthen experimental design, clarify metabolic interpretation, and support translational studies from exercise physiology to glycogen storage disease research.

• DiR: From Membrane Signal to EV Fate

  2026-09-07

  DiR (DiIC 18 (7)) is more than a membrane labeling dye: it can help distinguish extracellular vesicle biodistribution from true cargo delivery. This guide presents an assay-centered strategy for live imaging, fixed tissue analysis, and testing MPS escape claims.

• Letrozole: Translational Strategy Beyond Estrogen Suppressio

  2026-09-05

  Letrozole is more than a potent non-steroidal aromatase inhibitor: it is a translational tool for testing how estrogen availability, receptor signaling, endocrine feedback, and tissue context shape experimental outcomes. This article presents a mechanistic framework for breast cancer research, model validation, biomarker integration, and disciplined interpretation beyond the conventional product-page narrative.

• Trypsin-Responsive Nanomedicine for Acute Pancreatitis

  2026-09-04

  Wang and colleagues developed a biomimetic mesoporous organosilica nanoparticle that targets injured pancreatic acinar cells and releases BAPTA-AM in response to prematurely activated trypsin. In a mouse model, this upstream calcium-control strategy reduced pancreatic injury, improved biochemical outcomes, and increased survival, while also illustrating how disease-specific triggers can refine nanomedicine design.

• Cy5 Goat Anti-Rabbit IgG (H+L) Antibody for MAVS Assays

  2026-09-04

  Build sensitive MAVS and antiviral signaling assays with a far-red Cy5 conjugated secondary antibody designed for rabbit primary antibodies. This practical guide covers immunofluorescence, western blotting, flow cytometry, storage, controls, and troubleshooting for translating ASB3–MAVS biology into reproducible fluorescence data.

• ARCA Cy5 EGFP mRNA (5-moUTP): Delivery Guide

  2026-09-03

  ARCA Cy5 EGFP mRNA (5-moUTP) combines a Cy5-labeled delivery readout with EGFP translation reporting in 5-methoxyuridine modified mRNA. Its defined length, buffer, concentration, cap structure, and storage conditions support reproducible mRNA localization and translation efficiency assay design.

• EZ Cap Cy5 Firefly Luciferase mRNA Guide

  2026-09-03

  Learn how EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP), SKU R1010, separates mRNA uptake from productive translation in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers assay compatibility, transfection optimization, data interpretation, storage, and vendor selection using product specifications and peer-reviewed delivery research.

• FOXO3–YAP Dual Metabolic Targeting in HCC

  2026-09-02

  This study identifies FOXO3 as a tumor-suppressive regulator that simultaneously restrains glycolysis and glutaminolysis in hepatocellular carcinoma through direct repression of YAP. Its combination of promoter-level mechanism, metabolic assays, in vivo validation, and patient-derived organoids supports the FOXO3/YAP axis as a potential strategy for overcoming metabolic plasticity in HCC.

• Capecitabine in Patient-Derived Assembloids

  2026-09-02

  Learn how Capecitabine can be evaluated in matched tumor organoid–stroma systems to distinguish tumor-selective activation from microenvironment-driven resistance. This practical workflow combines prodrug handling, paired viability and mechanism assays, and troubleshooting strategies for translational oncology.

• One-step TUNEL Cy5 Apoptosis Detection Kit Guide

  2026-09-01

  Build a far-red apoptosis workflow for resistant cancer cells, suspension cultures, and tissue sections with practical controls and optimization checkpoints. The One-step TUNEL Cy5 Apoptosis Detection Kit connects DNA-fragmentation measurements to drug-response studies while preserving the distinction between an apoptosis-associated endpoint and direct pathway proof.

• Cy5 Secondary Antibody for MAVS Assay Design

  2026-09-01

  Learn how a Cy5 conjugated secondary antibody can strengthen MAVS–ASB3 experiments without confusing protein abundance with pathway activity. This evidence-led guide connects fluorescence assay design, causal controls, and practical reagent handling.

• Estradiol Benzoate and Translational ERα Strategy

  2026-08-31

  A thought-leadership guide to using Estradiol Benzoate as an estrogen receptor alpha agonist in mechanistic, biochemical, and cell-based research. The article connects assay design, receptor biology, translational rigor, and structure-guided discovery while clarifying why evidence from SARS-CoV-2 NSP15 screening should inform experimental discipline rather than be interpreted as evidence for an antiviral role.

• Cy5-UTP for RNA Labeling and LNP Studies

  2026-08-31

  Cy5-UTP enables direct, far-red visualization of RNA produced by T7 in vitro transcription, supporting FISH, dual-color arrays, and nucleic-acid delivery studies. Its strongest use-case is not merely labeling RNA, but connecting probe identity, intracellular localization, and delivery conditions in one experimentally controlled workflow.

8353 records 5/557 page Previous Next 12345 下5页 Last page